Ionis Pharmaceuticals, Inc. company logo
Ionis Pharmaceuticals, Inc. logo

Ionis Pharmaceuticals, Inc. (IONS)

Summary

Current Price
As of today, IONS price is $56.94, up +0.67% on
Current Price All-Time High
IONS price is currently -34.36% below its historical high of $86.74 set on
Market Cap
IONS current market cap is $9B, up +42.75% over the past 365 days
Revenue
IONS current annual revenue is $943.71M, up +33.83% year-over-year
Next Earnings
The next earnings release for IONS is on

Profile

Company profile for Ionis Pharmaceuticals, Inc. (IONS)
MetricValue
Full NameIonis Pharmaceuticals, Inc.
TickerNASDAQ: IONS
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websiteionis.com
Employees1,069

Key Metrics

Ionis Pharmaceuticals, Inc. Key Details
MetricValueDate
Price$56.94
Price, 1D Change+0.67%
Market Cap$9B
-
PE Ratio-
Beta0.21
Revenue$943.71M
Revenue, 1Y Change+33.83%
EPS-$2.38
EPS, 1Y Change+21.49%

Chart

SUGGESTED SERIES
Ionis Pharmaceuticals, Inc. chart

Events

Ionis Pharmaceuticals, Inc. Events
MetricValueDate
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeISIS
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

IONS Estimates
MetricValueDate
EPS-$2.38
EPS Estimate-$2.60N/A
EPS Est. Change-9.00%N/A
Revenue$943.71M
Revenue Estimate$920.76MN/A
Revenue Est. Change-2.43%N/A
Current Price$56.94
Price Target$90.00-
Price Tgt. Change+58.06%-

🔒 Log In To Unlock Full Data

EPS

IONS EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$2.54-$3.04-19.31%
-$1.66-$2.38-43.17%
-$2.60N/A-9.00%
-$1.16N/A+51.28%
IONS EPS reported versus estimate values chart

Revenue

IONS revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$620.13M$705.14M+13.71%
$897.47M$943.71M+5.15%
$920.76MN/A-2.43%
$1.40BN/A+48.51%
IONS revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

IONS Performance
MetricValueDate
Price, 1Y+36.74%
Price, 3Y+42.99%
Market Cap, 1Y+42.75%
Market Cap, 3Y+65.98%
Revenue, 1Y+33.83%
Revenue, 3Y+60.67%
EPS, 1Y+21.49%
EPS, 3Y-25.35%

🔒 Log In To Unlock Full Data

Technicals

IONS Technical Indicators
MetricValueDate
Current Price$56.94
SMA 200$74.65
SMA 50$66.96
EMA 200$68.32
EMA 50$63.89
MACD-$3.38
Beta0.21
ATR$2.40
14-Day RSI43.55
10-Day Volatility41.87%

Dividends

IONS Dividends
MetricValueDate
-N/A
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

IONS Income & Profitability
MetricValueDate
Revenue$943.71M
EPS-$2.38
Gross Profit$928.00M
Gross Margin98.31%
Operating Income-$382.00M
Operating Margin-40.47%
Net Income-$381.39M
Net Margin-40.36%
EBITDA-$358.99M

🔒 Log In To Unlock Full Data

Financial Health

IONS Financial Health
MetricValueDate
Debt To Equity5.24
1.95
1.94
-
2
1.23

Valuations

IONS Valuations
MetricValueDate
PE Ratio-
10.83
21.52
-16.90
-N/A

Balance Sheet

IONS Balance Sheet
MetricValueDate
Book Value$489.09M
$2.68B
$3.52B
$2.99B
$3.03B
$1.53B
Total Debt$2.61B
$1.18B
$28.08M

Expenses

IONS Expenses
MetricValueDate
$1.33B
$1.31B
$28.36M
$0.00
$22.69M
$0.00
$1.79M

Cash Flow

IONS Cash Flow
MetricValueDate
-$268.58M
-$277.78M
$675.84M
Capex$57.08M
-$325.67M

Recent analyst updates

IONS Recent analyst updates
MetricValueDate
JP Morgan
Wells Fargo
HC Wainwright & Co.
Guggenheim
Wolfe Research
RBC Capital
Morgan Stanley
HC Wainwright & Co.
Citigroup
Canaccord Genuity

Analyst sentiment

Sentiment over the past month
IONS analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
IONS institutional ownership distribution chart
No data

Screeners with IONS

FAQ

What is the ticker symbol for Ionis Pharmaceuticals, Inc.?
The ticker symbol for Ionis Pharmaceuticals, Inc. is NASDAQ:IONS
Does Ionis Pharmaceuticals, Inc. pay dividends?
No, Ionis Pharmaceuticals, Inc. does not pay dividends
What sector is Ionis Pharmaceuticals, Inc. in?
Ionis Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Ionis Pharmaceuticals, Inc. in?
Ionis Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Ionis Pharmaceuticals, Inc. based in?
Ionis Pharmaceuticals, Inc. is headquartered in United States
When did Ionis Pharmaceuticals, Inc. go public?
Ionis Pharmaceuticals, Inc. initial public offering (IPO) was on May 17, 1991
Is Ionis Pharmaceuticals, Inc. in the S&P 500?
No, Ionis Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Ionis Pharmaceuticals, Inc. in the NASDAQ 100?
No, Ionis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Ionis Pharmaceuticals, Inc. in the Dow Jones?
No, Ionis Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Ionis Pharmaceuticals, Inc. last earnings report?
Ionis Pharmaceuticals, Inc.'s most recent earnings report was on July 29, 2026
When does Ionis Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Ionis Pharmaceuticals, Inc. is November 4, 2026

Data Sources & References

  1. IONS Official Website www.ionis.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/874015/000087401526000115/0000874015-26-000115-index.htm
  3. IONS Profile on Yahoo Finance finance.yahoo.com/quote/IONS
  4. IONS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ions